Shell Companies
Compare Stocks
5 / 10Stock Comparison
NOEMU vs NRGV vs CCRN vs BE vs NEE
Revenue, margins, valuation, and 5-year total return — side by side.
Renewable Utilities
Medical - Care Facilities
Electrical Equipment & Parts
Regulated Electric
NOEMU vs NRGV vs CCRN vs BE vs NEE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Renewable Utilities | Medical - Care Facilities | Electrical Equipment & Parts | Regulated Electric |
| Market Cap | $99M | $784M | $426M | $62.75B | $194.14B |
| Revenue (TTM) | $0.00 | $217M | $761M | $2.45B | $27.93B |
| Net Income (TTM) | $1M | $-115M | $-99M | $6M | $8.18B |
| Gross Margin | — | 22.1% | 18.2% | 31.1% | 47.8% |
| Operating Margin | — | -35.8% | -0.9% | 8.2% | 29.5% |
| Forward P/E | 9999.0x | — | 156.2x | 123.5x | 23.0x |
| Total Debt | $12K | $95M | $2M | $2.99B | $95.62B |
| Cash & Equiv. | $953K | $58M | $109M | $2.45B | $2.81B |
NOEMU vs NRGV vs CCRN vs BE vs NEE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | May 26 | Return |
|---|---|---|---|
| CO2 Energy Transiti… (NOEMU) | 100 | 118.5 | +18.5% |
| Energy Vault Holdin… (NRGV) | 100 | 160.2 | +60.2% |
| Cross Country Healt… (CCRN) | 100 | 87.4 | -12.6% |
| Bloom Energy Corpor… (BE) | 100 | 493.6 | +393.6% |
| NextEra Energy, Inc. (NEE) | 100 | 118.1 | +18.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOEMU vs NRGV vs CCRN vs BE vs NEE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOEMU lags the leaders in this set but could rank higher in a more targeted comparison.
NRGV is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 340.9%, EPS growth 28.6%, 3Y rev CAGR 11.8%
- 340.9% revenue growth vs CCRN's -21.6%
CCRN is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.68, Low D/E 0.7%, current ratio 3.78x
BE ranks third and is worth considering specifically for long-term compounding.
- 9.4% 10Y total return vs NEE's 265.3%
- +14.1% vs CCRN's -5.2%
NEE carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 30 yrs, beta 0.19, yield 2.4%
- Beta 0.19, yield 2.4%, current ratio 0.60x
- Lower P/E (23.0x vs 123.5x)
- 29.3% margin vs NRGV's -53.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 340.9% revenue growth vs CCRN's -21.6% | |
| Value | Lower P/E (23.0x vs 123.5x) | |
| Quality / Margins | 29.3% margin vs NRGV's -53.0% | |
| Stability / Safety | Beta 0.19 vs BE's 3.62, lower leverage | |
| Dividends | 2.4% yield; 30-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +14.1% vs CCRN's -5.2% | |
| Efficiency (ROA) | 3.9% ROA vs NRGV's -40.3%, ROIC 4.1% vs -49.5% |
NOEMU vs NRGV vs CCRN vs BE vs NEE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NOEMU vs NRGV vs CCRN vs BE vs NEE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NEE leads in 2 of 6 categories
CCRN leads 1 • BE leads 1 • NOEMU leads 1 • NRGV leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NEE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NEE and NOEMU operate at a comparable scale, with $27.9B and $0 in trailing revenue. NEE is the more profitable business, keeping 29.3% of every revenue dollar as net income compared to NRGV's -53.0%. On growth, NRGV holds the edge at +156.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $217M | $761M | $2.4B | $27.9B |
| EBITDAEarnings before interest/tax | $788,698 | -$72M | $9M | $240M | $15.5B |
| Net IncomeAfter-tax profit | $1M | -$115M | -$99M | $6M | $8.2B |
| Free Cash FlowCash after capex | -$900,105 | -$98M | $40M | $233M | -$3.8B |
| Gross MarginGross profit ÷ Revenue | — | +22.1% | +18.2% | +31.1% | +47.8% |
| Operating MarginEBIT ÷ Revenue | — | -35.8% | -0.9% | +8.2% | +29.5% |
| Net MarginNet income ÷ Revenue | — | -53.0% | -13.0% | +0.2% | +29.3% |
| FCF MarginFCF ÷ Revenue | — | -45.2% | +5.2% | +9.5% | -13.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +156.4% | -100.0% | +130.4% | +7.3% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -42.9% | -6.0% | +3.3% | +160.0% |
Valuation Metrics
CCRN leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 28.3x trailing earnings, NEE trades at a 100% valuation discount to NOEMU's 9999.0x P/E. On an enterprise value basis, NEE's 18.7x EV/EBITDA is more attractive than NOEMU's 1515.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $99M | $784M | $426M | $62.8B | $194.1B |
| Enterprise ValueMkt cap + debt − cash | $98M | $820M | $320M | $63.3B | $286.9B |
| Trailing P/EPrice ÷ TTM EPS | 9999.00x | -6.97x | -4.50x | -705.49x | 28.30x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 156.16x | 123.47x | 23.02x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.63x |
| EV / EBITDAEnterprise value multiple | 1515.79x | — | 23.97x | 513.03x | 18.70x |
| Price / SalesMarket cap ÷ Revenue | — | 3.85x | 0.40x | 31.00x | 7.07x |
| Price / BookPrice ÷ Book value/share | 1.46x | 8.21x | 1.32x | 79.14x | 2.93x |
| Price / FCFMarket cap ÷ FCF | — | — | 10.63x | 1097.28x | — |
Profitability & Efficiency
Evenly matched — NOEMU and NEE each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
NEE delivers a 12.7% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-147 for NRGV. NOEMU carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BE's 3.77x. On the Piotroski fundamental quality scale (0–9), CCRN scores 6/9 vs BE's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.9% | -146.8% | -27.1% | +0.8% | +12.7% |
| ROA (TTM)Return on assets | +1.8% | -40.3% | -19.8% | +0.2% | +3.9% |
| ROICReturn on invested capital | -0.5% | -49.5% | -0.9% | +4.1% | +4.1% |
| ROCEReturn on capital employed | -0.7% | -53.7% | -0.8% | +2.5% | +4.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 6 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.00x | 1.07x | 0.01x | 3.77x | 1.44x |
| Net DebtTotal debt minus cash | -$941,339 | $36M | -$106M | $538M | $92.8B |
| Cash & Equiv.Liquid assets | $953,069 | $58M | $109M | $2.5B | $2.8B |
| Total DebtShort + long-term debt | $11,730 | $95M | $2M | $3.0B | $95.6B |
| Interest CoverageEBIT ÷ Interest expense | 156.21x | -10.33x | -1.39x | 1.05x | 1.99x |
Total Returns (Dividends Reinvested)
BE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BE five years ago would be worth $129,930 today (with dividends reinvested), compared to $4,637 for NRGV. Over the past 12 months, BE leads with a +1414.1% total return vs CCRN's -5.2%. The 3-year compound annual growth rate (CAGR) favors BE at 148.8% vs CCRN's -17.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +6.1% | -7.4% | +63.5% | +164.5% | +15.8% |
| 1-Year ReturnPast 12 months | +14.7% | +475.7% | -5.2% | +1414.1% | +39.7% |
| 3-Year ReturnCumulative with dividends | +18.6% | +163.4% | -43.9% | +1440.0% | +30.8% |
| 5-Year ReturnCumulative with dividends | +18.6% | -53.6% | -23.1% | +1199.3% | +37.4% |
| 10-Year ReturnCumulative with dividends | +18.6% | -53.1% | -9.9% | +944.1% | +265.3% |
| CAGR (3Y)Annualised 3-year return | +5.9% | +38.1% | -17.5% | +148.8% | +9.3% |
Risk & Volatility
NOEMU leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NOEMU is the less volatile stock with a -0.21 beta — it tends to amplify market swings less than BE's 3.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NOEMU currently trades 99.7% from its 52-week high vs NRGV's 71.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.21x | 2.97x | 0.68x | 3.62x | 0.19x |
| 52-Week HighHighest price in past year | $11.88 | $6.35 | $14.99 | $302.99 | $98.75 |
| 52-Week LowLowest price in past year | $10.28 | $0.65 | $7.43 | $16.47 | $63.88 |
| % of 52W HighCurrent price vs 52-week peak | +99.7% | +71.3% | +87.9% | +86.2% | +94.3% |
| RSI (14)Momentum oscillator 0–100 | 41.4 | 52.1 | 78.8 | 60.3 | 48.2 |
| Avg Volume (50D)Average daily shares traded | 26 | 3.7M | 578K | 10.2M | 8.4M |
Analyst Outlook
NEE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NRGV as "Buy", CCRN as "Hold", BE as "Buy", NEE as "Buy". Consensus price targets imply 54.5% upside for NRGV (target: $7) vs -28.1% for BE (target: $188). NEE is the only dividend payer here at 2.41% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $7.00 | $10.61 | $187.56 | $99.11 |
| # AnalystsCovering analysts | — | 7 | 14 | 31 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.0% | +2.4% |
| Dividend StreakConsecutive years of raises | — | — | 1 | 0 | 30 |
| Dividend / ShareAnnual DPS | — | — | — | $0.00 | $2.24 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.6% | 0.0% | 0.0% |
NEE leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). CCRN leads in 1 (Valuation Metrics). 1 tied.
NOEMU vs NRGV vs CCRN vs BE vs NEE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NOEMU or NRGV or CCRN or BE or NEE a better buy right now?
For growth investors, Energy Vault Holdings, Inc.
(NRGV) is the stronger pick with 340. 9% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). NextEra Energy, Inc. (NEE) offers the better valuation at 28. 3x trailing P/E (23. 0x forward), making it the more compelling value choice. Analysts rate Energy Vault Holdings, Inc. (NRGV) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOEMU or NRGV or CCRN or BE or NEE?
On trailing P/E, NextEra Energy, Inc.
(NEE) is the cheapest at 28. 3x versus CO2 Energy Transition Corp. Unit at 9999. 0x. On forward P/E, NextEra Energy, Inc. is actually cheaper at 23. 0x.
03Which is the better long-term investment — NOEMU or NRGV or CCRN or BE or NEE?
Over the past 5 years, Bloom Energy Corporation (BE) delivered a total return of +1199%, compared to -53.
6% for Energy Vault Holdings, Inc. (NRGV). Over 10 years, the gap is even starker: BE returned +944. 1% versus NRGV's -53. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOEMU or NRGV or CCRN or BE or NEE?
By beta (market sensitivity over 5 years), CO2 Energy Transition Corp.
Unit (NOEMU) is the lower-risk stock at -0. 21β versus Bloom Energy Corporation's 3. 62β — meaning BE is approximately -1807% more volatile than NOEMU relative to the S&P 500. On balance sheet safety, CO2 Energy Transition Corp. Unit (NOEMU) carries a lower debt/equity ratio of 0% versus 4% for Bloom Energy Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — NOEMU or NRGV or CCRN or BE or NEE?
By revenue growth (latest reported year), Energy Vault Holdings, Inc.
(NRGV) is pulling ahead at 340. 9% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: CO2 Energy Transition Corp. Unit grew EPS 100. 3% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, BE leads at 19. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOEMU or NRGV or CCRN or BE or NEE?
NextEra Energy, Inc.
(NEE) is the more profitable company, earning 24. 9% net margin versus -50. 9% for Energy Vault Holdings, Inc. — meaning it keeps 24. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEE leads at 30. 1% versus -36. 5% for NRGV. At the gross margin level — before operating expenses — NEE leads at 62. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOEMU or NRGV or CCRN or BE or NEE more undervalued right now?
On forward earnings alone, NextEra Energy, Inc.
(NEE) trades at 23. 0x forward P/E versus 156. 2x for Cross Country Healthcare, Inc. — 133. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NRGV: 54. 5% to $7. 00.
08Which pays a better dividend — NOEMU or NRGV or CCRN or BE or NEE?
In this comparison, NEE (2.
4% yield) pays a dividend. NOEMU, NRGV, CCRN, BE do not pay a meaningful dividend and should not be held primarily for income.
09Is NOEMU or NRGV or CCRN or BE or NEE better for a retirement portfolio?
For long-horizon retirement investors, NextEra Energy, Inc.
(NEE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 19), 2. 4% yield, +265. 3% 10Y return). Energy Vault Holdings, Inc. (NRGV) carries a higher beta of 2. 97 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NEE: +265. 3%, NRGV: -53. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOEMU and NRGV and CCRN and BE and NEE?
These companies operate in different sectors (NOEMU (Financial Services) and NRGV (Utilities) and CCRN (Healthcare) and BE (Industrials) and NEE (Utilities)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NOEMU is a small-cap quality compounder stock; NRGV is a small-cap high-growth stock; CCRN is a small-cap quality compounder stock; BE is a mid-cap high-growth stock; NEE is a mid-cap quality compounder stock. NEE pays a dividend while NOEMU, NRGV, CCRN, BE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.